IRVINE, Calif.–(BUSINESS WIRE)–Endologix LLC, a privately held, global medical device company dedicated to providing disruptive therapies for the interventional treatment of vascular disease, today announced that Matt Thompson, President and CEO, will present at the Life Science Intelligence (LSI) USA ’24 Emerging Medtech Summit. Scheduled for March 20, 2024, at 10:55 am PT on Track 3, Thompson will offer insights into the company’s innovative portfolio and its impact on vascular disease trea
Peripheral/Endo
Advancing Healthcare Access: Genesis MedTech Teams Up with Silk Road Medical to Serve Patients affected by Carotid Artery Disease in China
WUXI, China, March 7, 2024 /PRNewswire/ — Silk Road Medical (NASDAQ: SILK), a medical device company based in California USA and Genesis MedTech Group have signed an exclusive distribution agreement to introduce the TCAR® core products, ENROUTE® Transcarotid Neuroprotection System and…
New Viz.ai Study Demonstrates Reduced Mortality Rates in Patients with Pulmonary Embolism
SAN FRANCISCO–(BUSINESS WIRE)– #ai–Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced clinical data validating the impact of the Viz PE Solution in the management and outcomes of patients with pulmonary embolism (PE). The data was presented during the 2024 AVF (American Venous Forum) by Jacob Shapiro, M.D., vascular surgeon at TriHealth in Cincinnati, OH. The real-world study, “Shorter Time to Assessment and Anticoagulation with Decreased Mortalit
Nanoflex Robotics Installs First Remote-Ready Robotics System in North America for Vascular Interventions
The remote-ready robotics system, designed to be used for vascular interventions, was installed in The Jacobs Institute’s testing facility located within the University at Buffalo’s Canon Stroke and Vascular Research Center The Jacobs Institute site will be used for physician demonstrations and pre-clinical testing ZURICH, Switzerland, March 07, 2024 (GLOBE […]
Zylox-Tonbridge and Avinger Forge Strategic Partnership to Expand Disruptive OCT Solutions for Peripheral Vascular Interventions
HANGZHOU, China, March 7, 2024 /PRNewswire/ — Zylox-Tonbridge (2190.HK, “the Company”), a leading medical device company in the peripheral and neurovascular interventional market in China, today announced a new strategic partnership with Avinger, a commercial-stage medical device company…
La Jolla Vein & Vascular Proudly Announces World Lymphedema Day Patient Education Event
LA JOLLA, Calif.–(BUSINESS WIRE)–La Jolla Vein & Vascular, a leading provider of vascular health services in the San Diego area, is excited to announce their upcoming event today, the World Lymphedema Day Patient Education Event. This informative and educational function is scheduled to take place on March 6, 2024, in the practice lobby of La Jolla Vein & Vascular. Lymphedema, a condition affecting many individuals around the world, is a chronic disorder that can have a significant im
Shape Memory Medical Completes $38 Million in Financing to Advance Endovascular Embolization
SANTA CLARA, Calif.–(BUSINESS WIRE)–Shape Memory Medical Inc., developer of custom shape memory polymers for endovascular markets, announced today that it has completed $38 million in Series C financing led by Earlybird Venture Capital and with the participation of new and existing investors, including HBM Healthcare Investments (Cayman) Ltd., WexMed II […]
BD Initiates International Study to Expand Treatment Options for Patients with Peripheral Arterial Disease
First Patient Enrollment in AGILITY Study Begins Investigations of Safety and Effectiveness of BD Vascular Covered Stent for Treatment of PAD FRANKLIN LAKES, N.J., March 4, 2024 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company,…
Dr. Frank J. Veith Joins the Board of Directors of ViTAA Medical Solutions
MONTREAL–(BUSINESS WIRE)–ViTAA Medical Solutions, Inc., a leading innovator of precision vascular health designed to improve patient outcomes across the globe, is thrilled to announce the appointment of Frank J. Veith, M.D., a distinguished figure in the field of vascular surgery, to its Board of Directors. “I look forward to working […]
Endologix Initiates Percutaneous Transmural Arterial Bypass (PTAB)1 Post-Market Study
IRVINE, Calif.–(BUSINESS WIRE)–Endologix LLC, a privately held, global medical device company dedicated to providing disruptive therapies for the interventional treatment of vascular disease, announced today the initiation of the PTAB1 Post-Market Study. This study marks the beginning of a comprehensive post-market study aimed at evaluating the real-world performance of the […]
